title: Eicosanoid synthesis in children with cholestatic disease.
abstract: The possibility of malabsorption of triglycerides contained in the diets of children with cholestasis suggests a deficiency of essential fatty acids and, therefore, probable effects on eicosanoid metabolism. Children with either biliary atresia (BA) or syndromatic paucity of interlobular bile ducts (PILBD) were evaluated as to plasma and platelet total lipid fatty acid composition and synthesis of prostaglandins (PG) E1, PGE2, PGI2, PGF2, and thromboxane (TXB2) by whole blood incubated at 37 degrees C for 10 min. In both diseases linoleate deficiency was present as shown by low 18:2 fatty acids in plasma lipids. The children with BA had lower plasma arachidonate than controls but normal eicosanoid synthesis except for excess PGI2. Those with PILBD had low platelet arachidonate and were severely deficient in TXB2 synthesis (less than 10% of controls). Three children with PILBD were fed a supplement of structured triglyceride (Captex 810) intended to provide as much as 10% of energy as linoleate for 2-3 months. Results for these three cases suggested that insufficient linoleate was absorbed to increase plasma linoleate and differences in eicosanoids could not be attributed to linoleate supplementation.
authors.affiliation: Department of Food and Nutrition, Iowa State University, Ames 50011.
authors.forename: J
authors.initials: J
authors.lastname: Dupont
authors.forename: O
authors.initials: O
authors.lastname: Amédée-Manesme
authors.forename: D
authors.initials: D
authors.lastname: Pepin
authors.forename: J
authors.initials: J
authors.lastname: Chambaz
mesh_terms: D016718:Arachidonic Acid; D001095:Arachidonic Acids / Q000097:blood; D001656:Biliary Atresia / Q000097:blood / Q000188:drug therapy; D001792:Blood Platelets / Q000378:metabolism*; D002779:Cholestasis / Q000097:blood* / Q000188:drug therapy; D015777:Eicosanoids / Q000096:biosynthesis* / Q000097:blood; D005227:Fatty Acids / Q000097:blood; D005260:Female; D005526:Food, Formulated; D006801:Humans; D007223:Infant; D008041:Linoleic Acids / Q000627:therapeutic use; D008297:Male; D008722:Methods; D011453:Prostaglandins / Q000096:biosynthesis; D013931:Thromboxanes / Q000096:biosynthesis
chemical_list: D001095:Arachidonic Acids; D015777:Eicosanoids; D005227:Fatty Acids; D008041:Linoleic Acids; D011453:Prostaglandins; D013931:Thromboxanes; D016718:Arachidonic Acid